ORIGINAL INVESTIGATION

Size: px
Start display at page:

Download "ORIGINAL INVESTIGATION"

Transcription

1 ORIGINAL INVESTIGATION Effects of Exercise Programs to Prevent Decline in Health-Related Quality of Life in Highly Deconditioned Institutionalized Elderly Persons A Randomized led Trial Arnaud Dechamps, PhD; Philippe Diolez, PhD; Eric Thiaudière, PhD; Aurore Tulon, MSc; Chérifa Onifade, MD; Tuan Vuong, MD; Catherine Helmer, MD, PhD; Isabelle Bourdel-Marchasson, MD, PhD Background: Our objective was to assess the effects of targeted exercise programs on health-related quality of life compared with usual care based on the ability to perform activities of daily living (ADL) and the Neuropsychiatric Inventory scores in geriatric institutionalized persons. Methods: A randomized controlled trial of 2 exercise programs vs usual care was conducted in 160 institutionalized persons 65 years or older who were able to understand basic motor commands and to move from one position to another. Interventions were performed over 6 months and were either an adapted tai chi program (4 times 30 min/wk) or a cognition-action program (2 times min/wk) that focused primarily on an adapted guidance of patient-centered communication skills. The control group received usual care. The study was conducted at 4 settings. The main outcomes were changes in healthrelated quality of life based on ADL and Neuropsychiatric Inventory scores after 12 months. Results: The control group experienced a decline in ADL over the 12-month period compared with the adapted tai chi and cognition-action groups, but the differences were not significant (P=.24 and P=.15, respectively). Also, the components of ADL, eg, ability to walk, continence, and nutrition, were maintained better in the intervention groups than in the control group. The total Neuropsychiatric Inventory score also worsened significantly in the control group, while it was unchanged or improved in the intervention groups. The differences between the cognition-action group and the control group were significant (P.001). Neuropsychiatric diagnosis subgroups (such as dementia and psychosis) did not show a specific response from any intervention. Conclusion: Adapted exercise programs can slow down the decline in health-related quality of life among heterogeneous, institutionalized elderly persons. Trial Registration: clinicaltrials.gov Identifier: NCT Arch Intern Med. 2010;170(2): Author Affiliations: Department of Physical Activity and Exercise Psychology, LACES 4140, Faculté des Sciences du Sport (Dr Dechamps), and INSERM, U897 (Ms Tulon and Dr Helmer), Université Victor Segalen Bordeaux 2, Unité Mixte de Recherche 5536, CNRS/Université Victor Segalen Bordeaux 2 (Drs Diolez, Thiaudière, and Bourdel-Marchasson), and Department of Gerontology, Centre Hospitalier Universitaire de Bordeaux (Drs Onifade, Vuong, and Bourdel- Marchasson), Bordeaux, France; and Universitaire Medisch Centrum St Radboud, Nijmegen, the Netherlands (Dr Dechamps). FUNCTIONAL DEPENDENCE IN geriatric institutions raises important issues related to decline in overall healthrelated quality of life (HRQoL) and professional caregivers distress. Physical inactivity and disability in elderly institutionalized patients may negatively affect their ability to perform activities of daily living (ADL) and worsen their HRQoL status. 1-4 A meta-analysis has shown that exercise training can effectively improve HRQoL in persons with cognitive impairments. 5 Nevertheless, randomized controlled trials of exercise program implementation in geriatric settings are scarce. Moreover, frequent and severe behavioral disturbances, 6 severe deconditioning, lack of compliance, and assessment difficulties have compelled the majority of exercise intervention programs to exclude highly deconditioned and severely demented or psychotic institutionalized older adults. 2,7,8 Nonpharmacological, randomized, controlled trial interventions incorporating exercise have investigated the management of physical deterioration, undernutrition, and behavioral disturbances in demented patients, but their benefits in ADL have yet to be confirmed. 2,7-9 Although elderly persons with neuropsychiatric diagnoses and overall functioning impairments may be particularly good candidates for intervention to prevent decline, little is known regarding exercise program benefits on behavioral disturbances in this population. 5 No recommendations have been made about the structure and intensity of exercise programs to prevent decline in overall HRQoL in highly deconditioned el- 162

2 derly persons. We previously found that adapted tai chi (AT) exercises are feasible and effective in institutionalized elderly populations. 10 Another form of training program, named cognition-action (CA), which aims to increase adherence to exercise by adding a meaning to exercise in relation to everyday actions, could also be effective. Exercises in AT and CA are of light to moderate intensity and are designed to be harmless in a frail population. Instructors of AT need to have the mastery of tai chi; CA instructors could be physical activity teachers, occupational therapists, or physiotherapists who undergo training. Therefore, CA may be more accessible in institutions than AT. However, the efficacy of CA needs to be tested. The main objectives of this study were (1) to determine the clinical effectiveness of AT and CA interventions to improve HRQoL as assessed by changes in Katz and colleagues 11 index of ADL and Neuropspychiatric Inventory (NPI) scores 12 for highly deconditioned, institutionalized elderly persons; (2) to compare both groups with a routine care group; and (3) to identify which neuropsychiatric diagnoses could modify the effectiveness of the interventions. METHODS STUDY DESIGN This study was a 12-month multicenter, randomized, controlled trial of highly deconditioned, institutionalized elderly persons living in 4 settings close to Bordeaux, France. Enrollment began in May 2006 and follow-up ended in February Informed written consent was retrieved from the patient, guardian, or legal representative. When inclusion criteria were met and written informed consent was obtained, patient assignment was randomly determined by computer-generated random allocation number by a blind assigner, without any possibility of identification of the assignment allocation. All exercise sessions were conducted in groups and given at the patients facilities. The institutional review board of the University Hospital Centre, Bordeaux, France, approved the study protocol. PARTICIPANTS Two hundred seventy persons from 3 nursing homes and 1 longterm care home were screened during individual interviews (Figure). The inclusion criteria were broad: the participants had to be 65 years or older, had to be living in an institution for more than 6 months, had to have the ability to get up alone or with technical or human help if necessary, and had to have the ability to understand basic motor commands. Terminally ill and bedridden patients were excluded. A total of 160 patients were recruited from the nursing homes (n=121) and the long-term care home (n=39). The intervention groups consisted of either 6-month exercise programs of AT (n=51) or CA (n=49), and the control group consisted of routine care (n=60). The participants neuropsychiatric diagnoses were retrieved from their medical records. In case of doubt, an opinion was obtained from the research team using standard and comprehensive diagnostic measures for dementia types and psychiatric disorders. 13,14 Mini-Mental State Examination 15 scores were assessed for descriptive and statistical adjustment. Mini-Nutritional Assessment (MNA) scores below 17 were used to diagnose undernutrition. 16 Over a 1-week period, all assessments were completed by physicians who were not informed of treatment allocation. 51 Allocated to receive the Adapted Tai Chi exercise program 0 Did not receive allocated intervention 49 Assessed at 3 mo 2 Discontinued 2 Changed facility 45 Assessed at 6 mo 4 Discontinued 3 Died 1 Changed facility 6 Hospitalized > 24 h (different reasons) 41 Assessed at 12 mo 4 Discontinued 4 Died 270 Assessed for eligibility 160 Randomized 49 Allocated to receive the Cognition- Action program 0 Did not receive allocated intervention 49 Assessed at 3 mo 47 Assessed at 6 mo 2 Discontinued 1 Died 1 Changed facility 6 Hospitalized > 24 h (different reasons) 43 Assessed at 12 mo 4 Discontinued 3 Died 1 Changed facility Figure. Flow of participants in the study. INTERVENTIONS 110 Excluded 70 Not meeting inclusion criteria 40 Refused to participate 60 Allocated to receive usual care 0 Did not receive allocated intervention 56 Assessed at 3 mo 4 Discontinued 2 Died 2 Changed facility 54 Assessed at 6 mo 2 Discontinued 2 Died 4 Hospitalized > 24 h (different reasons) 51 Assessed at 12 mo 3 Discontinued 3 Died The planned class size was 8 patients per group. During interventions, the patients safety was ensured using adequate materials, and the intensity of the exercise was tailored according to the patients state. Both interventions were applied in addition to usual care. The AT classes were taught by an experienced instructor who followed an adapted variation of the Yang style for elderly persons, 17 which emphasizes body sensation, awareness of multidirectional weight shifting, body alignment, and multisegmental movement coordination. Deep breathing and muscular reinforcement exercises were integrated into the AT routine. Therefore, after the population characteristics were taken into consideration, AT was defined as 4 sessions of 30 minutes a week over the course of 6 months. The CA program was monitored by a trained physical activity teacher. Based on the reported frequency and duration of exercise from a pilot study, the CA group met for 30 minutes and progressed to 40 minutes twice a week for 6 months. 10 The CA intervention relied more on instructor guidance than on the type of exercise. The interrelationship with the patient was established with respect to the patient s perception. The instructor gave meaning to events and actions that helped the patient to find his or her own situational awareness and comfort in ADL. 10,18 Each session consisted of a 10-minute warm-up while participants were seated in a circle so that they could see each other. Lower limb movements (eg, cycling and knee elevations) alternated with upper body exercises (eg, arm rising and circle drawing) and were followed by stretching and resistance exercises against the hand of the instructor. The backs of chairs were used to secure balance exercises with the patients shifting their bodies and legs (front, back, and both sides) in a standing position. The participants, all seated, also passed a light and medium-size ball to the participants next to them, with their feet and arms at different heights. The sessions ended with deep-breathing exercises and relaxation. The exercises were 163

3 shown and explained using simple and short sentences. The CA instructor helped to contain the participants frustration during practice and solicited the remaining self-regulative resources. 18,19 Overall, in both groups (AT and CA), the exercises were light to moderate in intensity. The 2 intervention groups had 3 distinct characteristics: (1) AT was a movement-based approach, while CA was a guidance-centered approach; (2) speed of motion was predominantly slower in the AT group; and (3) the patients could rely more on procedural memory in CA, while the patients relied more on their learning capacity in AT. CONTROL GROUP The participants assigned to the control group received usual care with no additional attention or exercise or cognitivebehavioral training. This group had no restriction in nursing, medical care, counseling, physical activity, physiotherapy, or any health care support. ASSESSMENTS The primary patient outcome measures consisted of ADL scores and neuropsychiatric symptoms. The ADL, Mini-Mental State Examination, mood (Geriatric Depression Scale [GDS]), and NPI scores were assessed at baseline and at 6 and 12 months. Physical functioning measurements were evaluated at baseline and at 3, 6, and 12 months. Based on previous studies, a reduction in ADL impairment was unlikely. 8 We therefore judged primary outcomes as clinically successful if the patient showed a mean slowdown of 1 point in the total ADL impairment score compared with the control group and a reduction of 20 points in the NPI total score. 20 Main Outcome Assessments Katz and colleagues 11 index of ADL assesses the ability of participants to perform 6 ADL. Each item (bathing, dressing, using the toilet, walking, continence, and eating) was scored on a scale from 0 to 2 (0, able to perform the activity without any help; 1, able to perform the activity with little help; and 2, unable to perform the activity without complete help). Nursing staff members were interviewed for scoring. The total score ranged from 0 to 12. Behavioral disturbances were evaluated using the nursing home version of the NPI, 12 which consists of a 15- to 20- minute interview by a physician or a psychologist involving at least 2 staff members who usually care for the patient (range, 2-7 staff members, including a certified nurse). The nursing home version of the NPI includes 12 neuropsychiatric symptoms, including delusions, hallucinations, agitation/ aggression, depression/dysphoria, anxiety, euphoria/elation, apathy/indifference, disinhibition, irritability/lability, aberrant motor behavior, nighttime behavior, and eating disorders. The NPI scores range from 0 to 144; higher scores indicate greater behavioral disturbances. The impact of each neuropsychiatric symptom on caregiver occupational distress was rated from 0 (not at all) to 5 (very severely or extremely), and the total score ranged from 0 to 60. Physical Functioning and Mood Assessments Physical functioning was assessed using the Timed Up and Go test 21 (ie, time taken to rise from a chair, walk 3 minutes, return, and walk back to sit down); the chair rise test (time taken to rise 5 times from a chair), walking speed, and the 1-leg stance (time taken to stay in equilibrium while standing on 1 leg). Mood was assessed during a face-to-face interview using the 15-item GDS; the score ranges from 0 to 15, with higher scores indicating more depressive symptoms. 22 Assessments and records of adverse events were obtained by physicians on the research team, who stated whether the trial was involved in the events. STATISTICAL ANALYSIS This study was designed to have 90% power ( =.05) to detect a mean (SD) difference of 0.5 (0.8) point in the total ADL score. Because of patients poor physical status, the Timed Up and Go and the chair rise tests were categorized in 20 classes according to the baseline distribution for each variable. The inability to perform a test was modeled using an extra 21st category. The scores ranged from 1 to 21, with higher scores indicating performance impairment. To reinforce our results, 2 different types of statistical analysis were performed. First, we assessed changes in the outcome measures over time and between groups by using repeatedmeasures analysis of variance (at baseline and at 3, 6, and 12 months), with up to 4 observations per individual. Age, sex, Mini-Mental State Examination score, number of comorbidities, neuropsychiatric category, and baseline value of the dependent variable were used as covariates. Size effects were estimated (using the Cohen f effect size). To investigate the influence of neuropsychiatric categories, we conducted separate analyses within each neuropsychiatric diagnosis category using the same repeated-measures design described for primary analysis. Adherence was determined by presence at sessions. Residents who stopped participating or who missed a session for any reason (death, change of facility, or medical event) were considered absent. All analyses were conducted on an intentionto-treat basis, using all available data from all randomized patients and carrying forward the last observation for dropouts. P values were adjusted with Bonferroni correction. P values less than.05 were considered statistically significant. The second type of analysis was a linear mixed-effects model, adjusted according to age and sex. This model allows exploration of the slope of changes in major end points (ADL and NPI scores) over 1 year. RESULTS BASELINE CHARACTERISTICS The mean (SD) age of the participants was 82.3 (9.1) years (age range, years). The participants were predominantly female (71.7%). At baseline, there was a trend for better health status for participants in the AT group compared with controls, and the ADL score was lower (better) for the AT participants than for the controls (f=7.002; P=.009) (Table 1 and Table 2). INTERVENTION COMPLIANCE, ATTRITION, AND ADVERSE EVENTS Class sizes in both intervention groups ranged from 5 to 11 participants (mean, 8 participants). Of the 160 patients who began the study, 146 completed the 6-month assessments and 135 completed the 12-month assessments (Figure). Participants who did not complete the study (n=25) did not differ from the other participants (n=135) in any of the baseline variables except for the patients who were older and who died during follow-up 164

4 Table 1. Characteristics of the Study s at Baseline Variable AT (n=51) CA (n=49) ( 2 =4.63; P=.03). Attendance rates for the 6-month period were similar in both exercise groups (mean [SD], 48.9% [29.8%] in the CA group and 38.8% [32.3%] in the AT group). None of the observed deaths (n=18) was directly or indirectly attributable to an adverse effect due to the intervention. PRIMARY OUTCOMES (n=60) Age, mean (SD), y 83 (8.6) 83.2 (8.3) 80.9 (10.1) Female, No. (%) 39 (76.5) 31 (63.3) 45 (75.0) Weight, mean (SD), kg 63.1 (15.8) 61.4 (12.9) 62.9 (15.3) Undernutrition, 9 (18.4) 7 (16.3) 20 (35.7) MNA 17.0, No. (%) Alzheimer disease, No. (%) 9 (17.6) 15 (30.6) 21 (35.0) Other dementia, No. (%) 16 (31.4) 13 (26.5) 20 (33.3) Psychotic troubles, No. (%) 7 (13.7) 10 (20.4) 15 (25.0) Depressed, No. (%) 6 (11.8) 3 (6.1) 1 (1.7) Other or undiagnosed, No. (%) 13 (25.5) 8 (16.3) 3 (5.0) MMSE, mean (SD), (9.3) 14.2 (9.3) 14.8 (7.8) GDS, mean (SD), (3.0) 7.1 (3.9) 6.7 (3.3) TUG test, mean (SD), (6.6) 11.9 (6.3) 12.3 (6.4) Chair rise test, 12.0 (6.7) 11.9 (6.3) 13.0 (6.7) mean (SD), m Walking speed, 0.58 (0.29) 0.52 (0.36) 0.53 (0.36) mean (SD), m/s OLS, mean (SD), s 1.3 (2.0) 0.8 (1.9) 0.8 (2.3) HGS, mean (SD), kg 16.0 (10.0) 15.3 (9.1) 14.2 (8.7) Abbreviations: AT, adapted tai chi; CA, cognition-action; GDS, Geriatric Depression Scale; HGS, hand grip strength in kilograms on the best hand; MMSE, Mini-Mental State Examination; MNA, Mini-Nutritional Assessment; OLS, 1-leg stance in seconds on the best leg; TUG, Timed Up and Go. After 6 months, significant differences from ADL total scores were observed between groups according to the multivariate analysis of variance model (Table 3). While the control group experienced a significant decline in the total ADL score (adjusted mean difference [AMD], 1.56; 95% confidence interval [CI], 1.02 to 2.10; P.001), no significant changes in the total ADL scores were observed in the intervention groups (AMD, 0.36; 95% CI, 0.43 to 1.15 in the AT group, and AMD, 0.09; 95% CI, 0.90 to 0.72 in the CA group). Over the 12-month period, the control group had a larger decline in the ADL score (AMD, 1.57; 95% CI, 0.83 to 2.31) compared with the intervention groups (AMD, 0.70; 95% CI, 6 to 0.96 in the AT group, and AMD, 0.71; 95% CI, 0.36 to 1.07 in the CA group), P=.007. Using the mixed-effects model, the change in the total ADL score over 12 months was not significantly different between the CA group and the control group ( = 0.07/ mo; P=.16) or between the AT group and the control group ( = 0.06/mo; P=.24). However, walking abilities were better preserved in the CA group than in the control group ( =.02/mo; P=.03); continence was better preserved in the AT group than in the control group ( = 0.02/mo; P=.04); and eating was better preserved in both groups than Table 2. Main Outcome Measures: Activities of Daily Living (ADL) and Neuropsychiatric Inventory (NPI) Scores at Baseline Variable AT (n=51) Mean (SD) CA (n=49) in the control group ( = 0.03/mo; P=.02 in the AT group, and = 0.03/mo; P=.02 in the CA group). Patients in the control group significantly increased their total NPI score at 6 months (AMD, 9.9; 95% CI, 2.0 to 17.6; P.001) and over the 12-month observation period (AMD, 14.2; 95% CI, 5.4 to 23.0; P.001) (Table 4). In the CA group, the total NPI score was reduced in a clinically significant way from baseline to 6 months (P.001) and to 12 months (P.001). The caregivers distress increased over the 1-year period in the control group (P=.006), while it remained somewhat constant in the CA group and was reduced significantly in the AT group (P=.02). Using the mixed-effects model, the evolution of NPI scores over the 1-year period was significantly better in the CA group compared with the control group ( = 1.14/ mo; P=.03) but did not differ between the AT group and the control group ( = 0.80/mo; P=.12). We found that the increase in the total NPI score over the 12-month period increased the risk of the ADL worsening in the whole population (OR, 1.14; 95% CI, 1.04 to 1.25; P=.005). Overall, when the CA and AT interventions were compared with each other according to both models, no difference was shown for main outcomes. FUNCTIONAL TESTING AND MOOD (n=60) ADL, (3.6) a 4.7 (3.9) 5.3 (3.9) Bathing 1.0 (0.8) a 1.2 (0.9) 1.4 (0.8) Dressing 0.8 (0.8) b 1.1 (0.9) 1.2 (0.9) Using the toilet 0.4 (0.7) c 0.6 (0.8) 0.7 (0.9) Walking 0.3 (0.6) 0.4 (0.6) 0.5 (0.8) Continence 0.7 (0.8) b 1.0 (0.9) 1.1 (0.8) Eating 0.3 (0.6) 0.5 (0.6) 0.5 (0.7) Total NPI score, (19.0) 25.9 (23.1) 27.9 (29.7) Total NPI distress score, (8.7) 9.8 (7.8) 9.1 (11.8) Delusions 2.9 (4.5) 3.6 (4.2) 3.9 (5.1) Hallucinations 0.7 (2.5) 1.3 (3.5) 1.0 (3.0) Agitation 1.9 (3.4) 3.4 (4.2) 3.4 (4.8) Depression 2.2 (3.3) 1.9 (3.2) 1.8 (3.7) Anxiety 2.2 (3.3) 2.2 (3.5) 3.0 (4.7) Euphoria 0.5 (1.6) 0.8 (2.3) 1.2 (3.4) Apathy 2.4 (3.6) 3.0 (4.0) 3.3 (5.0) Disinhibition 0.8 (2.0) 1.5 (3.3) 1.0 (3.1) Irritability 2.3 (3.8) 3.5 (3.8) 3.8 (5.0) Aberrant motor behavior 1.9 (3.7) 3.0 (4.4) 3.2 (4.9) Nighttime behavior 0.7 (2.1) 0.1 (0.7) 0.5 (2.2) Eating change 0.3 (1.5) 1.5 (3.3) 1.7 (3.7) Abbreviations: AT, adapted tai chi; CA, cognition-action. a P.01 (AT group vs control group). b P.02 (AT group vs control group). c P.05 (AT group vs control group). After 6 months, the performance of the participants in the control group significantly worsened during the 165

5 Table 3. Adjusted Mean Difference per Patient in MMSE Score, ADL Score, and Mood Over the 12-Month Study Period a Baseline to 6 Months (Intervention), Baseline to 12 Months (Intervention and Follow-up), AT CA P AT Variable (n=45) (n=47) (n=54) Value (f ) (n=41) MMSE ( 4.25 to 0.38) ( 1.91 to 1.77) ADL ( 0.43 to 1.15) ( 0.90 to 0.72) Bathing ( 0.16 to 0.25) ( 0.41 to 0.06) Dressing (0 to 0.20) (7 to 0.19) Using the toilet ( 0.12 to 0.21) ( 0.40 to 0.06) Walking ( 0.08 to 0.04) (6 to 0.18) Continence (0.33) 0.02 ( 0.12 to 0.30) (0.17 to 0.61) c (0.03 to 0.33) c Eating (4 to 0.09) c ( 0.18 to 0.22) GDS (0.14) 1.4 ( 2.7 to 0.7) c ( 3.8 to 1.7) c ( 2.5 to 0.9) c ( 3.1to0.3) CA (n=43) (n=51) P Value (f ) b (0.76) ( 4.34 to 0.74) c.13 (0.70) 0.75 ( 3.74 to 2.99) ( 3.33 to 1.93) ( 3.70 to 0.41) (0.29) (1.02 to 2.10) c.001 (0.42) 0.70 (6 to 0.96) ( 0.36 to 1.07) (0.83 to 2.31) (0.42) (0.37) (0.10 to 0.37) c ( 0.13 to 0.33) (3 to 0.33) (0.06 to 0.38) c (0.33) (0.33) (0.19 to 0.50) c (0.12 to 0.58) c ( 0.31 to 0.26) ( 0.05 to 0.43) (0.42) (0.14) (0.10 to 0.37) c ( 0.12 to 0.32) ( 0.14 to 0.44) ( 0.14 to 0.42) (0.29) (0.25) (0.11 to 0.47) c ( 0.08 to 0.33) (8 to 0.33) (0.01 to 0.58) c (0.31) (1 to 0.16) (0.02 to 0.52) c (0.18 to 0.62) c (0.29) (0.37) (0.12 to 0.42) a ( 0.30 to 0.10) (1 to 0.41) (0.13 to 0.63) c (0.42) ( 4.8 to 1.8) c ( 1.6to0.8) Abbreviations: ADL, activities of daily living; AT, adapted tai chi; CA, cognition-action; CI, confidence interval; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Examination. a Repeated measures were adjusted for baseline measure, age, sex, MMSE score, neuropsychiatric diagnoses, and number of comorbidities; data are basedon comparison of repeated adjusted time times treatment groups; and f is the Cohen f effect size. b Adjusted repeated design with baseline and 6- and 12-month values; results are in intention to treat, with the last observation carried forward for missing data. c Indicates the within-group adjusted mean difference (P.05). Table 4. Adjusted Mean Difference per Patient in Behavioral Disturbances Over the 12-Month Study Period a Baseline to 6 Months (Intervention), Baseline to 12 Months (Intervention and Follow-up), AT CA P AT CA P Variable (n=45) (n=47) (n=54) Value (f ) (n=41) (n=43) (n=51) Value (f ) b Delusions (0.26) (0.37) ( 1.9to0.2) ( 2.0to1.1) ( 0.9to2.5) ( 1.2to1.7) ( 2.5to0.6) (0.3 to 3.9) c Hallucinations (0.10) (0.10) ( 1.0to0.5) ( 0.8to1.7) (to1.0) ( 0.7to0.4) ( 1.0to0.3) ( 1.3to1.0) Agitation (0.32) (0.37) ( 2.2to0.4) ( 2.7to0.3) c (0.6 to 3.7) c ( 2.2to0.6) ( 2.9 to 1.1) c ( 0.1to3.3) Depression (0.23) (0.29) ( 1.3to1.1) ( 1.6 to ) c ( 0.6to2.4) ( 1.2to0.5) ( 1.2to0.5) ( 0.3to2.6) Anxiety (0.13) (0.24) ( 1.5to1.2) ( 1.7to0.5) ( 1.4to2.3) ( 2.7 to 0.8) c ( 1.9to0.5) ( 0.8to2.8) Euphoria (0.10) (0.10) (to0.1) ( 0.9to0.5) ( 1.0to0.8) ( 0.7to0.1) ( 0.9 to 0.7) c ( 1.5to0.0) c Apathy (0.37) (0.44) ( 1.3to0.7) ( 2.1to0.1) ( 1.8to3.4) c ( 1.7to1.3) ( 1.9to0.7) (0.3 to 4.0) c Disinhibition (0.17) (0.24) ( 1.4to0.4) ( 1.0to1.3) ( 0.1to2.3) ( 1.5to0.4) ( 1.2to1.0) (0.1 to 2.9) c Irritability (0.27) (0.42) ( 0.6to1.7) ( 0.8to2.1) (0.3 to 3.5) c ( 1.3to1.0) ( 2.0 to ) c (0.5 to 3.5) c Aberrant motor (0.13) (0.28) behavior ( 1.2to1.0) ( 2.3to0.5) ( 1.5to2.2) ( 0.8to1.4) ( 1.2to1.6) (1.0 to 4.7) Nighttime (0.13) (0.13) behavior ( 0.7to1.3) ( 0.4to0.1) ( 1.5to0.8) ( 0.8to0.6) ( 0.5to1.5) ( 0.17 to 2.0) Eating change (0.23) (0.24) (0.05 to 2.2) c ( 1.0to0.6) ( 0.4to2.8) ( 2.0 to ) c ( 1.1to0.6) ( 1.1to0.6) Total NPI score (0.34) (0.55) ( 8.2to5.4) ( 11.6 to 2.0) (2.0 to 17.6) c ( 9.4to1.5) ( 11.4 to 1.8) (5.4 to 23.0) c Total distress (0.27) (0.32) score ( 3.5to2.0) ( 4.6to1.9) (0.5 to 4.6) c ( 6.4to1.6) c ( 3.9to3.2) ( 5.1to0.0) c Abbreviations: AT, adapted tai chi; CA, cognition-action; CI, confidence interval; NPI, Neuropsychiatric Inventory. a Repeated measures were adjusted for baseline measure, age, sex, Mini-Mental State Examination score, neuropsychiatric diagnoses, and number of comorbidities; data are based on comparison of repeated adjusted time times treatment groups; and f is the Cohen f effect size. b Adjusted repeated design with baseline and 6- and 12-month values; results are in intention to treat, with the last observation carried forward for missing data. c Indicates the within-group adjusted mean difference (P.05). 166

6 Table 5. Adjusted Mean Difference per Patient in Functional Testing Over the 12-Month Study Period a Baseline to 3 Months, Baseline to 6 Months (Intervention), OR (95% CI) AT (n=49) TUG test 0.1 ( 1.2to1.4) Chair rise test 0.6 ( 2.2to1.2) 10-m Walking 0.03 speed, m/s ( 0.30 to 0.10) OLS, s 0.9 HGS, kg 1.7 ( 3.5to0.1) CA (n=49) (n=56) AT (n=45) 0.3 ( 1.2to1.7) 1.0 (to2.2) 0.9 ( 1.7to3.4) ( 2.8to0.5) (2.1 to 4.4) d ( 3.0to2.7) ( 0.06 to 0.09) ( 0.12 to 0.01) d ( 0.15 to 0.12) (0.2 to 1.6) d (0.0 to 2.3) d ( 0.4 to 0.1) d (to1.9) ( 2.5to0.6) CA (n=47) ( 4.9 to 2.7) d ( 4.8to0.4) d ( 3.2 to 2.7) (n=54) P Value (f ) b 0.5 ( 1.7to2.8) 2.5 (0.8 to 4.2) d.46 (0.33) (0.29) ( 3.8 to 1.6) (0.7 to 5.1) d (0.20) ( 0.12 to 0.12) (5 to 0.08) d (0.20) (0.8 to 2.9) d ( 0.7to0.9) (0.38) ( 7.8 to 5.0) d AT (n=41) TUG test 1.6 ( 1.1to4.4) Chair rise test 0.4 ( 3.3to4.2) 10-m Walking 0.10 speed, m/s OLS, s 0.7 ( 0.8to2.2) Baseline to 12 Months (Intervention and Follow-up), CA (n=43) (n=51) P Value (f ) c 2.3 (to4.7) 2.3 (0.2 to 4.3) d.61 (0.14) (0.29) ( 5.1to2.6) ( 3.0to2.3) (5 to 0.05) d (5 to 0.03) d (2 to 0.02) d (0.23) HGS, kg 5.3 ( 7.5 to 3.0) d 3.0 ( 6.5to0.4) (0.4 to 2.3) d ( 0.8to1.7).002 (0.82) (0.44) ( 8.2 to 4.8) d Abbreviations: AT, adapted tai chi; CA, cognition-action; CI, confidence interval; HGS, hand grip strength in kilograms on the best hand; NPI, Neuropsychiatric Inventory; OLS, 1-leg stance in seconds on the best leg; OR, odds ratio; TUG, Timed Up and Go. a Repeated measures were adjusted for baseline measure, age, sex, Mini-Mental State Examination score, neuropsychiatric diagnoses, and number of comorbidities; data are based on comparison of repeated adjusted time times treatment groups; and f is the Cohen f effect size. b Adjusted repeated design with baseline and 3- and 6-month values. c Adjusted repeated design with baseline and 3-, 6-, and 12-month values; results are in intention to treat, with the last observation carried forward for missing data. d Indicates the within-group adjusted mean difference (P.05). Timed Up and Go test (P=.003) and the chair rise test (P.001), and their walking speed declined (P.001), while the intervention groups showed no improvement or worsening (Table 5). At 12 months, the walking speed significantly declined in all groups (AT group, P =.03; CA group, P =.02; and control group, P.001). Depressive symptoms were reduced on the GDS at 6 months in all 3 groups (AT group, P=.002 and f=0.75; CA group, P.001 and f=0.94; and control group, P.001 and f=0.64) and were maintained at 12 months in both intervention groups (AT group, P=.004 and f=0.96; CA group, P.001 and f=1.27) (Table 3). Specific analysis demonstrated that, when compared with their randomized peers, psychotic participants, demented patients of any stage, and undiagnosed participants had a similar response to the interventions (data not shown). COMMENT This study demonstrated that targeted exercise intervention programs can slow the decline in HRQoL in deconditioned, institutionalized elderly persons, even in those with severe neuropsychiatric disability. Our results showed that, while 5 out of the 6 basic ADL scores significantly worsened in the control group, the participants who benefited from the interventions showed a reduction in the functional degradation process according to the adjusted multivariate analysis of variance model. However, clinical significance was not achieved because the ADL difference was below the threshold of 1 point (range, 0-12 points), and the results of the mixed-effects model did not confirm this effect. Despite randomization, the participants in the AT group were less disabled than those in the control group. This outcome could have modified their 1-year response to exercise. However, interventions have modified the course of some of the ADL items according to both models. The observed maintenance of the ADL continence score in the AT group may have been triggered by the exercise training and environmental factors, as were the walking capacities in the CA group. While no data are available regarding the effect of tai chi on continence in institutionalized elderly persons, it has been shown that continence outcomes were better in nursing home patients who were in an exercise intervention group compared with usual care. 23 Both inter- 167

7 ventions were associated with better preservation of the self-feeding capacity, which is the last ability to deteriorate during the disabling process. We found similar ADL worsening in neuropsychiatric diagnosis subgroups or across dementia stages, thus confirming the small differences in the decline profiles across demented and non-alzheimer dementia populations. 24 Possibly, the advanced deconditioning of the institutionalized population may have blurred the distinction between specific worsening patterns. It is noteworthy that living conditions were similar for all residents within each institution. Overall, these results indicated that severely deconditioned elderly patients with various neuropsychiatric diagnoses and health conditions could all benefit from adapted exercise interventions with a trained instructor s guidance. Conversely, the increase in behavioral disturbances observed in the control group may presumably have played a role in the worsening of the ADL scores. However, no data are available from institutions to support this statement to date. The residents in the CA group were less agitated and showed less depressive symptoms, suggesting some interrelationships with the quality-of-life improvement process. In contrast with physical activity recommendations and the dose-response paradigm, the current results did not show additional benefits from the increased number of sessions in the improvement of the outcome measures. Possibly, the apparent lack of dose effect may be attributable to differences in exercise intensity or to a reduction of the exercise response capacity because of physical inactivity and disability. Further research should include metabolic noninvasive assessment such as phosphorus 31 nuclear magnetic resonance spectroscopy to examine muscle properties and exercise adaptability. 25 To our knowledge, this is the first intervention study to report the detailed changes of the NPI symptom scores over a 1-year period. Our population had the particularity of having high behavioral disturbances scores on the NPI compared with those previously described, 8,9 probably because we chose not to exclude residents with behavioral problems. The CA intervention method reduced agitation, irritability, overall total NPI score, and depression on the GDS, findings that are in agreement with those of a previous study. 9 Compared with the control group, the CA group showed a reduction in the total NPI score, however, below what we have stated as clinically significant: 20 points in the total score. Although we did not find significant differences between the intervention groups, the observed effect magnitudes and clinically significant outcomes were greater in the CA group, especially in the management of behavioral disturbances. The CA benefits may have been emotionally triggered by the enhanced self-confidence resulting from the adapted guidance model, social stimulation, and exercise repetitions during the sessions. The time spent with the residents independently from exercise may have played a role in the effect of intervention, and a control group with an intervention that is not based on a physical activity may have different outcomes compared with our control group. However, the AT intervention included a longer contact time with the instructor compared with the CA intervention, and the outcomes were not better. Further investigations and targeted individualized interventions are needed to determine to what extent management of behavioral disturbances could benefit from such a program combining physical intervention and personal attention. The reduction of the caregivers distress showed that professionals may have benefited from the interventions. We have not explored this fact from a nursing home management point of view, and the underlying processes of this improvement need to be investigated. The effect sizes were promising with respect to implementation and replication in other geriatric institutions. The intrinsic nature of the interventions did not allow a double-blind study. To limit the possible bias, assessors were independent and the nursing staff members were not informed about intervention allocation (AT or CA); however, they could not be unaware that the residents were attending an exercise group. Each ADL or NPI assessment involving staff interviews were separated by a long time (6 months), and it is likely that the staff did not keep the precedent scores in mind. Because we analyzed changes of scores rather than the scores themselves, we believe that our results are not greatly affected by observer bias, nor can contamination between groups be observed. In this study, we excluded the residents who were unable or unwilling to participate. However, the attendance reflects daily life in nursing homes, where the bedridden residents or the residents who are opposed to occupational activities are not compelled to participate. The target population of these interventions could be simply defined according to the inclusion criteria of the study: residents who were able to stand and to understand basic motor commands and who were not opposed to attending a physical activity group. We did not perform any cost-effectiveness analysis in this study. The costs related to impaired quality of life could include various items. Predefined conditions related to incontinence or low physical activity have been previously used for this purpose. 23 However, in this last study, despite positive effects on outcomes, no costeffectiveness of an exercise program was shown. Severe acute events (eg, hospitalization or death) occurred at a similar rate in the 3 groups, and medication changes did not differ between the groups (data not shown); therefore, in this institutionalized population with fixed costs for nursing, it is unlikely that these interventions were cost-effective. However, it is obvious that an intervention with 2 sessions per week would be less expensive than one with 4 sessions per week, and the total expense per person in the CA group was less than 200/y. Considering the effects of the interventions on dependency and behavior, and the possible decrease of caregiver distress, this expense seemed reasonable. In conclusion, exercise programs offer promising benefits for the prevention of HRQoL decline in institutionalized elderly persons. The CA intervention, which included an adapted guidance for physical activity, tended to provide better and more sustained results than the AT intervention. The intervention programs showed high adaptability across different populations, which makes these materials adaptable to other set- 168

8 tings. Further evaluations are needed to determine the cost-effectiveness of these promising interventions within institutions and their effects on caregivers welfare. Accepted for Publication: October 7, Correspondence: Isabelle Bourdel-Marchasson, MD, PhD, Pole de Gérontologie, Centre Henry Choussat, Hôpital Xavier Arnozan, Pessac, France Author Contributions: Study concept and design: Dechamps and Bourdel-Marchasson. Acquisition of data: Onifade and Vuong. Analysis and interpretation of data: Dechamps, Diolez, Thiaudière, Tulon, Vuong, Helmer, and Bourdel-Marchasson. Drafting of the manuscript: Dechamps, Onifade, Vuong, and Bourdel-Marchasson. Critical revision of the manuscript for important intellectual content: Dechamps, Diolez, Thiaudière, Helmer, and Bourdel-Marchasson. Statistical analysis: Tulon and Helmer. Obtained funding: Bourdel-Marchasson. Administrative, technical, and material support: Bourdel- Marchasson. Study supervision: Bourdel-Marchasson. Financial Disclosure: None reported. Funding/Support: This study was supported by a grant from the Conseil Régional d Aquitaine (CR T0115 R ). Additional Contributions: Lucile Lafont, Laboratoire LACES 4140, Université Victor Segalen Bordeaux 2, provided valuable assistance and support. REFERENCES 1. Andersen CK, Wittrup-Jensen KU, Lolk A, Andersen K, Kragh-Sorensen P. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes. 2004;2: Lazowski DA, Ecclestone NA, Myers AM, et al. A randomized outcome evaluation of group exercise programs in long-term care institutions. J Gerontol A Biol Sci Med Sci. 1999;54(12):M621-M Pham M, Pinganaud G, Richard-Harston S, Decamps A, Bourdel-Marchasson I. Prospective audit of diabetes care and outcomes in a group of geriatric French care homes. Diabetes Metab. 2003;29(3): Richardson J, Bedard M, Weaver B. Changes in physical functioning in institutionalized older adults. Disabil Rehabil. 2001;23(15): Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil. 2004;85(10): Dechamps A, Jutand MA, Onifade C, Richard-Harston S, Bourdel-Marchasson I. Co-occurrence of neuropsychiatric syndromes in demented and psychotic institutionalized elderly. Int J Geriatr Psychiatry. 2008;23(11): Ayalon L, Gum AM, Feliciano L, Arean PA. Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med. 2006;166(20): Rolland Y, Pillard F, Klapouszczak A, et al. Exercise program for nursing home residents with Alzheimer s disease: a 1-year randomized, controlled trial. JAm Geriatr Soc. 2007;55(2): Teri L, Gibbons LE, McCurry SM, et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003; 290(15): Dechamps A, Onifade C, Decamps A, Bourdel-Marchasson I. Health-related quality of life in frail institutionalized elderly: effects of a cognition-action intervention and Tai Chi. J Aging Phys Act. 2009;17(2): Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10(1): Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12): American Psychiatric Association Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer s disease: report of the NINCDS-ADRDA Work under the auspices of Department of Health and Human Services Task Force on Alzheimer s Disease. Neurology. 1984;34(7): Folstein MF, Folstein SE, McHugh PR. Mini-Mental State : a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition: the Mini Nutritional Assessment. Clin Geriatr Med. 2002;18(4): Li F, Fisher KJ, Harmer P, McAuley E, Wilson NL. Fear of falling in elderly persons: association with falls, functional ability, and quality of life. J Gerontol B Psychol Sci Soc Sci. 2003;58(5):P283-P Csikszentmihalyi M. Finding Flow: The Psychology of Engagement With Everyday Life. New York, NY: Basic Books; Miller W, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed. New York, NY: Guilford Press; Wang LY, Shofer JB, Rohde K, et al. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Geriatr Psychiatry. 2009;17(9): Podsiadlo D, Richardson S. The timed Up & Go : a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2): Lesher EL, Berryhill JS. Validation of the Geriatric Depression Scale Short Form among inpatients. J Clin Psychol. 1994;50(2): Schnelle JF, Kapur K, Alessi C, et al. Does an exercise and incontinence intervention save healthcare costs in a nursing home population? J Am Geriatr Soc. 2003;51(2): Wicklund AH, Johnson N, Rademaker A, Weitner BB, Weintraub S. Profiles of decline in activities of daily living in non-alzheimer dementia. Alzheimer Dis Assoc Disord. 2007;21(1): Bourdel-Marchasson I, Biran M, Dehail P, et al. Muscle phosphocreatine postexercise recovery rate is related to functional evaluation in hospitalized and community-living older people. J Nutr Health Aging. 2007;11(3):

Health-related quality of life in frail institutionalized elderly: effects of. UMR 5536 CNRS/Université V Segalen Bordeaux 2, Bordeaux, France

Health-related quality of life in frail institutionalized elderly: effects of. UMR 5536 CNRS/Université V Segalen Bordeaux 2, Bordeaux, France Page 1 of 26 Journal of Aging and Physical Activity (c) Human Kinetics, Inc. Health-related quality of life in frail institutionalized elderly: effects of cognition-action intervention and Tai Chi Arnaud

More information

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients Blackwell Science, LtdOxford, UKPCNPsychiatry and Clinical Neurosciences1323-13162005 Blackwell Publishing Pty Ltd593274279Original ArticleDementia and mild AlzheimersJ. Shimabukuro et al. Psychiatry and

More information

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Measure Description Percentage of patients with dementia for whom there was a documented screening* for behavioral

More information

Neuropsychiatric Inventory Nursing Home Version (NPI-NH)

Neuropsychiatric Inventory Nursing Home Version (NPI-NH) This is a Sample version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) The full version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) comes without sample watermark..

More information

Health-Related Quality of Life in Frail Institutionalized Elderly: Effects of a Cognition-Action Intervention and Tai Chi

Health-Related Quality of Life in Frail Institutionalized Elderly: Effects of a Cognition-Action Intervention and Tai Chi PRACTICAL APPLICATIONS Journal of Aging and Physical Activity, 2009, 17, 236-248 2009 Human Kinetics, Inc. Health-Related Quality of Life in Frail Institutionalized Elderly: Effects of a Cognition-Action

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Atri A, Frölich L, Ballard C, et al. Effect of idalopirdine as adjunct to cholinesterase inhibitors on in cognition in patients with Alzheimer disease: three randomized clinical

More information

NEUROPSYCHOMETRIC TESTS

NEUROPSYCHOMETRIC TESTS NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract

More information

Alzheimer s disease (AD) results in a progressive deterioration

Alzheimer s disease (AD) results in a progressive deterioration CLINICAL INVESTIGATIONS Exercise Program for Nursing Home Residents with Alzheimer s Disease: A 1-Year Randomized, Controlled Trial Yves Rolland, MD, PhD, wz Fabien Pillard, MD, w Adrian Klapouszczak,

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) FOCUSED QUESTION Does the Tailored Activity Program (TAP) for dementia patients reduce caregiver burden and neuropsychiatric behavior compared to a wait-list control group

More information

Neuropsychiatric Syndromes

Neuropsychiatric Syndromes Neuropsychiatric Syndromes Susan Czapiewski,MD VAHCS December 10, 2015 Dr. Czapiewski has indicated no potential conflict of interest to this presentation. She does intend to discuss the off-label use

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) Friedmann, E., Galik, E., Thomas, S. A, Hall, P. S, Chung, S. Y., & McCune, S. (2015). Evaluation of a pet-assisted living intervention for improving functional status

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a preprint version which may differ from the publisher's version. For additional information about this

More information

The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables

The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2005; 20: 531 536. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.1317 The course of neuropsychiatric

More information

4/26/2012. Laura Grooms, MD Assistant Professor Geriatric Medicine Department of Family and Geriatric Medicine University of Louisville April 20, 2012

4/26/2012. Laura Grooms, MD Assistant Professor Geriatric Medicine Department of Family and Geriatric Medicine University of Louisville April 20, 2012 Laura Grooms, MD Assistant Professor Geriatric Medicine Department of Family and Geriatric Medicine University of Louisville April 20, 2012 Laura Grooms, MD Assistant Professor Geriatric Medicine Department

More information

K. Kahle-Wrobleski 1, J.S. Andrews 1, M. Belger 2, S. Gauthier 3, Y. Stern 4, D.M. Rentz 5, D. Galasko 6

K. Kahle-Wrobleski 1, J.S. Andrews 1, M. Belger 2, S. Gauthier 3, Y. Stern 4, D.M. Rentz 5, D. Galasko 6 The Journal of Prevention of Alzheimer s Disease - JPAD Volume 2, Number 2, 2015 Clinical and Economic Characteristics of Milestones along the Continuum of Alzheimer s Disease: Transforming Functional

More information

QUESTIONNAIRE: Finland

QUESTIONNAIRE: Finland QUESTIONNAIRE: Finland To put the assessment and management of behavioural disorders into a broader context of social and health policy and services in Finland, some background information is presented.

More information

The Neuropsychiatric Inventory Questionnaire: Background and Administration

The Neuropsychiatric Inventory Questionnaire: Background and Administration The Neuropsychiatric Inventory Questionnaire: Background and Administration The Neuropsychiatric Inventory Questionnaire (NPI-Q) was developed and crossvalidated with the standard NPI to provide a brief

More information

Common Chronic diseases An Evidence Base for Yoga Intervention in Advanced Years & at End of Life

Common Chronic diseases An Evidence Base for Yoga Intervention in Advanced Years & at End of Life Common Chronic diseases An Evidence Base for Yoga Intervention in Advanced Years & at End of Life Coronary artery disease Arthritis Hypertension Diabetes mellitus Obesity 1 2 Taking it easy Contributes

More information

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP Dementia and Fall Geriatric Interprofessional Training Wael Hamade, MD, FAAFP Prevalence of Dementia Age range 65-74 5% % affected 75-84 15-25% 85 and older 36-50% 5.4 Million American have AD Dementia

More information

Alzheimer's Disease - Activities of Daily Living Inventory AD-ADL

Alzheimer's Disease - Activities of Daily Living Inventory AD-ADL This is a Sample version of the Alzheimer's Disease - Activities of Daily Living Inventory AD-ADL The full version of the Alzheimer's Disease - Activities of Daily Living Inventory AD-ADL comes without

More information

CORRECTED COPY Department of Veterans Affairs VHA DIRECTIVE Veterans Health Administration Washington, DC December 9, 2010

CORRECTED COPY Department of Veterans Affairs VHA DIRECTIVE Veterans Health Administration Washington, DC December 9, 2010 CORRECTED COPY Department of Veterans Affairs VHA DIRECTIVE 2010-054 Veterans Health Administration Washington, DC 20420 CATASTROPHICALLY DISABLED VETERAN EVALUATION, ENROLLMENT, AND CERTAIN COPAYMENT-EXEMPTIONS

More information

Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials

Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials Alzheimer s & Dementia 4 (2008) 390 394 Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials Donald J. Connor a, *, Marwan N. Sabbagh a, Jeffery L. Cummings b a Cleo

More information

Fall Prevention For Older People In Care Homes Julie Whitney 20 th June 2017

Fall Prevention For Older People In Care Homes Julie Whitney 20 th June 2017 Fall Prevention For Older People In Care Homes Julie Whitney 20 th June 2017 Falls in care homes Community Care home Cognitive impairment Fallers 30% 50% 67% Falls rate PPPY 0.65 1.4 2.4 Injury 10-30%

More information

Introduction to Dementia: Complications

Introduction to Dementia: Complications Introduction to Dementia: Complications Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:

More information

Effectiveness of Physical Activity for Improving Functional Ability of Older Adults with Dementia

Effectiveness of Physical Activity for Improving Functional Ability of Older Adults with Dementia Pacific University CommonKnowledge Mental Health CATs OT Critically Appraised Topics 2010 Effectiveness of Physical Activity for Improving Functional Ability of Older Adults with Dementia Catherine Steele

More information

Exercise, Physical Therapy and Fall Prevention

Exercise, Physical Therapy and Fall Prevention Exercise, Physical Therapy and Fall Prevention University of Davis Medical Center Rosy Chow Neuro Clinical Specialist Physical Therapist Outline of Talk Role of Physical Therapy in care of people with

More information

Therapeutic Benefits of Caregiver Interventions

Therapeutic Benefits of Caregiver Interventions Therapeutic Benefits of Caregiver Interventions Laura N. Gitlin, Ph.D. Professor, Department Community Public Health, School of Nursing Director, Center for Innovative Care in Aging Johns Hopkins University

More information

Behavioral Interventions

Behavioral Interventions Behavioral Interventions Linda K. Shumaker, R.N.-BC, MA Pennsylvania Behavioral Health and Aging Coalition Behavioral Management is the key in taking care of anyone with a Dementia! Mental Health Issues

More information

Sensitivity and Specificity of the Minimal Chair Height Standing Ability Test: A Simple and Affordable Fall-Risk Screening Instrument

Sensitivity and Specificity of the Minimal Chair Height Standing Ability Test: A Simple and Affordable Fall-Risk Screening Instrument Sensitivity and Specificity of the Minimal Chair Height Standing Ability Test: A Simple and Affordable Fall-Risk Screening Instrument By: Nadia C. Reider, MSc ; Patti-Jean Naylor, PhD ; Catherine Gaul,

More information

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Professor Clive Ballard Dr Byron Creese University of Exeter, UK Guardian guide for 2018: Top

More information

Physical & Functional Assessments in Older Adults

Physical & Functional Assessments in Older Adults Physical & Functional Assessments in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, CGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) Li, R., Cooper, C., Barber, J., Rapaport, P., Griffin, M., & Livingston, G. (2014). Coping strategies as mediators of the effect of the START (strategies for RelaTives)

More information

The Long-term Prognosis of Delirium

The Long-term Prognosis of Delirium The Long-term Prognosis of Jane McCusker, MD, DrPH, Professor, Epidemiology and Biostatistics, McGill University; Head, Clinical Epidemiology and Community Studies, St. Mary s Hospital, Montreal, QC. Nine

More information

CLUSTERING OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA (BPSD): A EUROPEAN ALZHEIMER S DISEASE IN CONSORTIUM (EADC) STUDY

CLUSTERING OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA (BPSD): A EUROPEAN ALZHEIMER S DISEASE IN CONSORTIUM (EADC) STUDY 426 Original articles CLUSTERING OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA (BPSD): A EUROPEAN ALZHEIMER S DISEASE IN CONSORTIUM (EADC) STUDY M. Petrovic 1,2, C. Hurt 2, D. Collins 2, A. Burns

More information

10/17/2017. Causes of Dementia Alzheimer's Disease Vascular Dementia Diffuse Lewy Body Disease Alcoholic Dementia Fronto-Temporal Dementia Others

10/17/2017. Causes of Dementia Alzheimer's Disease Vascular Dementia Diffuse Lewy Body Disease Alcoholic Dementia Fronto-Temporal Dementia Others 1 Dementia Dementia comes from the Latin word demens, meaning out of mind. It is the permanent loss of multiple intellectual functions. It is progressive deterioration of mental powers accompanied by changes

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Porsteinsson AP, Drye LT, Pollock BG, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized controlled trial. JAMA. doi:10.1001/jama.2014.93 eappendix.

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms State of the art lecture March 4-2012 Philippe H Robert, Philippe Nice - France Robert The diagnosis of AD Neuropsychiatric

More information

Nutritional Assessment in frail elderly. M. Secher, G.Abellan Van Kan, B.Vellas 1st December 2010 Firenze

Nutritional Assessment in frail elderly. M. Secher, G.Abellan Van Kan, B.Vellas 1st December 2010 Firenze Nutritional Assessment in frail elderly M. Secher, G.Abellan Van Kan, B.Vellas 1st December 2010 Firenze Frailty definition Undernutrition as part of the frailty syndrome Nutritional assessment in frail

More information

Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer s disease (amended)

Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer s disease (amended) Issue date: November 2006 (amended September 2007) Review date: September 2009 Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer s disease (amended) Includes a

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) FOCUSED QUESTION Is an individualized occupational therapy program more effective in modulating mood disturbances and functional deficits than general skills training for

More information

Functional Assessment Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico

Functional Assessment Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico Retired - Geriatrics/Extended Care New Mexico Veterans Affairs Healthcare System Albuquerque, NM Disclosure Statement:

More information

PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE

PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE 166 Chemerinski et al. DEPRESSION AND ANXIETY 7:166 170 (1998) PREVALENCE AND CORRELATES OF ANXIETY IN ALZHEIMER S DISEASE Erán Chemerinski, M.D., 1 * Gustavo Petracca, M.D., 1 Facundo Manes, M.D., 2 Ramón

More information

Psychosis and Agitation in Dementia

Psychosis and Agitation in Dementia Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University

More information

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer s Disease

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer s Disease ORIGINAL RESEARCH Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer s Disease Hadas Benhabib 1, Krista L. Lanctôt, PhD 1,2,4, Goran M. Eryavec, MD, FRCPC 3,4,

More information

Recognition and Management of Behavioral Disturbances in Dementia

Recognition and Management of Behavioral Disturbances in Dementia Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic

More information

Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD

Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD World Health Organization Geneva (Switzerland) December 1, 2016 World Health Organization.

More information

Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer s disease and their caregivers

Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer s disease and their caregivers International Psychogeriatrics (2008), 20:2, 383 393 C 2007 International Psychogeriatric Association doi:10.1017/s1041610207006254 Printed in the United Kingdom Reliability of the Brazilian Portuguese

More information

Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

Mellen Center Approaches Exercise in MS

Mellen Center Approaches Exercise in MS Mellen Center Approaches Exercise in MS Framework: Physical exercise is generally recommended to promote fitness and wellness in individuals with or without chronic health conditions. Implementing and

More information

Anosognosia, or loss of insight into one s cognitive

Anosognosia, or loss of insight into one s cognitive REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and

More information

What is Occupational Therapy?

What is Occupational Therapy? Introduction to Occupational Therapy Services What is Occupational Therapy? Alice Chan, OTI Tai Po Hospital a health profession that focuses on promoting health and well being through engagement in meaningful

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

UC San Francisco UC San Francisco Previously Published Works

UC San Francisco UC San Francisco Previously Published Works UC San Francisco UC San Francisco Previously Published Works Title The Course of Functional Impairment in Older Homeless Adults: Disabled on the Street. Permalink https://escholarship.org/uc/item/5x84q71q

More information

Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian

Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian German Center for Neurodegenerative Diseases (DZNE), site

More information

Severity and prevalence of behavioral and psychological symptoms among patients of different dementia stages in Taiwan

Severity and prevalence of behavioral and psychological symptoms among patients of different dementia stages in Taiwan Original article Severity and prevalence of behavioral and psychological symptoms among patients of different dementia stages in Taiwan Si-Sheng Huang 1, Wen-Fu Wang 2, Yi-Cheng Liao 1 1 Department of

More information

Known as both a thief and murderer,

Known as both a thief and murderer, &A Dementia Drugs: When Should They Be Stopped? Ron Keren, MD, FRCPC As presented at the University of Toronto s Primary Care Conference, Toronto, Ontario (May 25) Known as both a thief and murderer, Alzheimer

More information

SYNOPSIS (FOR NATIONAL AUTHORITY USE ONLY) INDIVIDUAL STUDY TABLE REFERRING TO PART OF THE DOSSIER

SYNOPSIS (FOR NATIONAL AUTHORITY USE ONLY) INDIVIDUAL STUDY TABLE REFERRING TO PART OF THE DOSSIER SYNOPSIS Protocol No.: RIS-USA-63 Psychosis in Alzheimer s disease (PAD) analysis Title of Study: A randomized, double-blind, placebo controlled study of risperidone for treatment of behavioral disturbances

More information

Management of the Acutely Agitated Long Term Care Patient

Management of the Acutely Agitated Long Term Care Patient Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia

More information

Worldwide, over 40 million people have. Pimavanserin in Alzheimer s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms

Worldwide, over 40 million people have. Pimavanserin in Alzheimer s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms The Journal of Prevention of Alzheimer s Disease - JPAD Volume 6, Number 1, 2019 Original Research The Author(s) Pimavanserin in Alzheimer s Disease Psychosis: Efficacy in Patients with More Pronounced

More information

Measuring health-related quality of life in persons with dementia DOMS results & recommendations

Measuring health-related quality of life in persons with dementia DOMS results & recommendations Measuring health-related quality of life in persons with dementia DOMS results & recommendations Madeleine King, Siggi Zapart, Jan Sansoni, Nick Marosszeky On behalf of the Dementia Outcomes Measurement

More information

October 28, Geriatrics Update Course. Lesley Wiesenfeld, MD, MHCM, FRCPC. Managing BPSD. Geriatric Psychiatrist, Mount Sinai Hospital

October 28, Geriatrics Update Course. Lesley Wiesenfeld, MD, MHCM, FRCPC. Managing BPSD. Geriatric Psychiatrist, Mount Sinai Hospital October 28, 2016 Geriatrics Update Course Managing BPSD Lesley Wiesenfeld, MD, MHCM, FRCPC Geriatric Psychiatrist, Mount Sinai Hospital Disclosures ~No Pharmaceutical or Industry Support ~ No Health Without

More information

Cumulated Ambulation Score to evaluate mobility is feasible in geriatric patients and in patients with hip fracture

Cumulated Ambulation Score to evaluate mobility is feasible in geriatric patients and in patients with hip fracture Cumulated Ambulation Score to evaluate mobility is feasible in geriatric patients and in patients with hip fracture Morten Tange Kristensen 1, 2,Thomas Linding Jakobsen 3, 4, Jesper Westphal Nielsen 1,

More information

DEMENTIA MEASURES GROUP OVERVIEW

DEMENTIA MEASURES GROUP OVERVIEW DEMENTIA MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN DEMENTIA MEASURES GROUP: #47 Care Plan #280 Dementia: Staging of Dementia #281 Dementia: Cognitive Assessment

More information

Cognitive and Behavioral Changes in ALS: A Guide for People with ALS and their Families

Cognitive and Behavioral Changes in ALS: A Guide for People with ALS and their Families Cognitive and Behavioral Changes in ALS: A Guide for People with ALS and their Families Overview If you had asked doctors about ALS 15 years ago, the majority of providers would have told you that ALS

More information

The Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme

The Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme The Chinese University of Hong Kong The Nethersole School of Nursing CTP 004 Evidence-based Practice for Dementia Care Web-based Course Module II for Professional Social and Health Care Workers. 1 Chapter

More information

Scottish Pilot of the Tailored Activity Programme Progress to date. Jenny Reid AHP Dementia Consultant NHS

Scottish Pilot of the Tailored Activity Programme Progress to date. Jenny Reid AHP Dementia Consultant NHS Scottish Pilot of the Tailored Activity Programme Progress to date Jenny Reid AHP Dementia Consultant NHS Lothian @JennyAHPDem Overview of seminar Setting the scene What is TAP? The National TAP pilot

More information

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES.

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA NEXT-Link DEMENTIA is a network of Danish

More information

Functional Ability Screening Tools for the Clinic

Functional Ability Screening Tools for the Clinic Functional Ability Screening Tools for the Clinic Shelley Hockensmith,, P.T., NCS Objectives Review screening tools for physical or functional ability including Five Times Sit to Stand, Walking Speed,

More information

Communication with Cognitively Impaired Clients For CNAs

Communication with Cognitively Impaired Clients For CNAs Communication with Cognitively Impaired Clients For CNAs This course has been awarded one (1.0) contact hour. This course expires on August 31, 2017. Copyright 2005 by RN.com. All Rights Reserved. Reproduction

More information

Evaluation of the functional independence for stroke survivors in the community

Evaluation of the functional independence for stroke survivors in the community Asian J Gerontol Geriatr 2009; 4: 24 9 Evaluation of the functional independence for stroke survivors in the community ORIGINAL ARTICLE CKC Chan Bsc, DWC Chan Msc, SKM Wong MBA, MAIS, BA, PDOT ABSTRACT

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (Review of TA 111) Appraisal

More information

Chapter 3: Methodology

Chapter 3: Methodology Chapter 3: Methodology STUDY DESIGN A Randomized Controlled Trial STUDY SETTING The present study was carried out in 4 old age homes in Mangalore and nearby regions. TARGET POPULATION Elderly subjects,

More information

DESCRIPTION: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months

DESCRIPTION: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Prevention, Treatment, and Management of Mental Health 2019 COLLECTION

More information

WHAT IS THE ROLE OF EXERCISE IN PREVENTING FALLS AND FRACTURES IN LONG-TERM CARE?

WHAT IS THE ROLE OF EXERCISE IN PREVENTING FALLS AND FRACTURES IN LONG-TERM CARE? WHAT IS THE ROLE OF EXERCISE IN PREVENTING FALLS AND FRACTURES IN LONG-TERM CARE? CAITLIN MCARTHUR, PHD, MScPT, BSc(KIN) POST-DOCTORAL FELLOW GERAS CENTRE FOR AGING RESEARCH MCMASTER UNIVERSITY ABOUT ME...

More information

SYNOPSIS. Risperidone-R064766: Clinical Study Report RIS-USA-232 (FOR NATIONAL AUTHORITY USE ONLY)

SYNOPSIS. Risperidone-R064766: Clinical Study Report RIS-USA-232 (FOR NATIONAL AUTHORITY USE ONLY) SYNOPSIS Protocol No.: RIS-USA-232 Title of Study: Efficacy and Safety of a Flexible Dose of Risperidone Versus Placebo in the Treatment of Psychosis of Alzheimer's Disease Principal Investigator: M.D.

More information

Created in January 2005 Duration: approx. 20 minutes

Created in January 2005 Duration: approx. 20 minutes 1 1 The Timed Up and Go Test Created in January 2005 Duration: approx. 20 minutes 2 Credits 2005 Stein Gerontological Institute. All rights reserved. Principal medical contributors: Alan Katz, MD Francois

More information

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,

More information

Prevention of falls in older age: The role of physical activity. Dr Anne Tiedemann Senior Research Fellow

Prevention of falls in older age: The role of physical activity. Dr Anne Tiedemann Senior Research Fellow Prevention of falls in older age: The role of physical activity Dr Anne Tiedemann Senior Research Fellow Fall definition Prevention of Falls Network Europe (ProFaNE) definition 1 : an unexpected event

More information

Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-alzheimer s dementia

Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-alzheimer s dementia STEER 2002; Vol 2: No.2 Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-alzheimer s dementia Bunmi Fajemisin Evidence search date: November 2001 www.signpoststeer.org

More information

Psychological therapies for people with dementia who have associated depression [New 2015].

Psychological therapies for people with dementia who have associated depression [New 2015]. Psychological therapies for people with dementia who have associated depression [New 2015]. SCOPING QUESTION: For people with dementia and comorbid depression, do psychological interventions (including

More information

Geriatrics and Cancer Care

Geriatrics and Cancer Care Geriatrics and Cancer Care Roger Wong, BMSc, MD, FRCPC, FACP Postgraduate Dean of Medical Education Clinical Professor, Division of Geriatric Medicine UBC Faculty of Medicine Disclosure No competing interests

More information

NSG330:Review of Literature: Paper 2. To determine the efficacy of non-pharmacological methods of

NSG330:Review of Literature: Paper 2. To determine the efficacy of non-pharmacological methods of Non-pharmacological Treatments 1 NSG330:Review of Literature: Paper 2 To determine the efficacy of non-pharmacological methods of treating agitation in the demented patient, a literature review of five

More information

ORIGINAL CONTRIBUTION. The Spectrum of Behavioral Responses to Cholinesterase Inhibitor Therapy in Alzheimer Disease

ORIGINAL CONTRIBUTION. The Spectrum of Behavioral Responses to Cholinesterase Inhibitor Therapy in Alzheimer Disease ORIGINAL CONTRIBUTION The Spectrum of Behavioral Responses to Cholinesterase Inhibitor Therapy in Alzheimer Disease Michael S. Mega, MD, PhD; Donna M. Masterman, MD; Susan M. O Connor, RNC; Terry R. Barclay,

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) Crain, A. L., Enstad, C. J., Hanson, L. R., Kreitzer, M., Lewis, B. A., & Whitebird, R. R. (2012). Mindfulness-based stress reduction for family caregivers: A randomized

More information

Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer s diseasepcn_

Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer s diseasepcn_ Psychiatry and Clinical Neurosciences 2012; 66: 227 234 doi:10.1111/j.1440-1819.2011.02315.x Regular Article Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer s diseasepcn_2315

More information

A Study of relationship between frailty and physical performance in elderly women

A Study of relationship between frailty and physical performance in elderly women Original Article Journal of Exercise Rehabilitation 2015;11(4):215-219 A Study of relationship between frailty and physical performance in elderly women Bog Ja Jeoung 1, *, Yang Chool Lee 2 1 Department

More information

Admission Criteria Continued Stay Criteria Discharge Criteria. All of the following must be met: 1. Member continues to meet all admission criteria

Admission Criteria Continued Stay Criteria Discharge Criteria. All of the following must be met: 1. Member continues to meet all admission criteria CMS Local Coverage Determination (LCD) of Psychiatry and Psychology Services for Massachusetts, New York, and Rhode Island L33632 Outpatient Services Coverage Indications and Limitations Hospital outpatient

More information

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of Focused Issue of This Month Diagnosis and Treatment for Behavioral and Psychological Symptoms of Dementia Byoung Hoon Oh, MD Department of Psychiatry, Yonsei University College of Medicine E - mail : drobh@yuhs.ac

More information

Multifactorial risk assessments and evidence-based interventions to address falls in primary care. Objectives. Importance

Multifactorial risk assessments and evidence-based interventions to address falls in primary care. Objectives. Importance Multifactorial risk assessments and evidence-based interventions to address falls in primary care Sarah Ross, DO, MS Assistant Professor Internal Medicine, Geriatrics Nicoleta Bugnariu, PT, PhD Associate

More information

The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL)

The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL) The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL Sue J. Kang, M.S., Seong Hye Choi, M.D.*, Byung H. Lee, M.A., Jay C. Kwon, M.D., Duk L. Na, M.D., Seol-Heui Han

More information

IT IS WELL known that individuals with dementia. Classifying eating-related problems among institutionalized people with dementia.

IT IS WELL known that individuals with dementia. Classifying eating-related problems among institutionalized people with dementia. doi:10.1111/pcn.12375 Regular Article Classifying eating-related problems among institutionalized people with dementia Shunichiro Shinagawa, MD, PhD, 1 * Kazuki Honda, MD, PhD, 2 Tetsuo Kashibayashi, MD,

More information

The Pleasant Events Schedule-AD: Psychometric Properties and Relationship to Depression and Cognition in Alzheimer's Disease Patients 1

The Pleasant Events Schedule-AD: Psychometric Properties and Relationship to Depression and Cognition in Alzheimer's Disease Patients 1 Copyright 1997 by The Cerontological Society of America The Cerontologist Vol.37, No. 1,40-45 The Pleasant Events Schedule-AD (PES-AD) has been described as a useful tool for identifying pleasant activities

More information

Research Article Are Dementia Patient s Engagement Using Tailored Stimuli the Same? The Apathy Dilemma in Nursing Home Residents

Research Article Are Dementia Patient s Engagement Using Tailored Stimuli the Same? The Apathy Dilemma in Nursing Home Residents Hindawi Publishing Corporation Current Gerontology and Geriatrics Research Volume 2012, Article ID 942640, 11 pages doi:10.1155/2012/942640 Research Article Are Dementia Patient s Engagement Using Tailored

More information

Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers

Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2002; 17: 29±34. DOI: 10.1002/gps.510 Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers

More information

DEMENTIA MEASURES GROUP OVERVIEW

DEMENTIA MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: DEMENTIA MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DEMENTIA MEASURES GROUP: #280. Dementia: Staging of Dementia #281. Dementia: Cognitive Assessment #282. Dementia:

More information

Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic

Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic Original Articles 179 Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic Ching-Sen Shih 1, Sui-Hing Yan 2, Ying-Hoo Ho 1, Yuh-Te Lin 1, Jie-Yuan Li 1, and Yuk-Keung Lo 1 Abstract-

More information